 |
Ryan Kelly
|
E-mail: kelly403@umn.edu
Thesis Advisor: Bruce
Blazar
Year entered: 2004
Degrees received:
B.S., Biochemistry, California Polytechnic State University,
San Luis Obispio, CA 2000
Associates Degree of General Studies, Saddleback College,
Mission Viejo, CA 1998
Honors and Awards:
-
Graduate School Doctoral Dissertation Fellowship, 2008-2009
-
Best Graduate Student Presentation, Pediatric Research,
Education and Scholarshiop symposium 2008
-
MICaB Student Travel Award, Spring 2008
- National Institutes of Health (NIH) Immunology Predoctoral
Training Grant, 2006-2008
- Children’s Cancer Research Fund (CCRF) Grant, 2005,
2006
- Bone Marrow Transplant Research Fund Grant, 2005, 2006
Committees:
- MICaB Career Development Committee, 2007-present
- MICaB Faculty Admission Committee, 2006-2007
Thesis research:
The immune deficiency following BMT is a leading cause of
morbidity and mortality among BMT recipients. My research
aims to develop therapies to speed recovery of the thymus
and peripheral T cell compartment following BMT using novel
combination small molecule therapies. We utilize a clinically
relevant murine BMT model system to investigate the therapeutic
benefit of combinatorial administration of KGF, androgen regulators
and general radioprotectants in restoring thymic function
and T-cell reconstitution post-BMT. We have used several useful
techniques to assess thymic function, output and T-cell-driven
immune responses against a pathogen post-BMT. In addition,
my research in investigates the importance of (1) miRNA in
TEC development, (2) thymocyte-derived signals in driving
TEC regeneration following TBI-induced injury and (3) the
potential of adult-derived and/or embryonic stem cells to
differentiate into thymic epithelial cells in vitro
and/or in vivo.
Publications:
- RM Kelly, SL Highfill, A Panoskaltsis-Mortari, PA Taylor,
RL Boyd, GA Holländer, and Bruce R. Blazar. 2008. “Keratinocyte
Growth Factor and Androgen Blockade Work in Concert to Protect
Against Conditioning Regimen-Induced Thymic Epithelial Damage
and Enhance T-Cell Reconstitution Following Murine Bone
Marrow Transplantation”, Blood,
in press, advance online publication March 11. * Selected
by editor-in-chief to be highlighted in"Inside Blood"
commentary*
- JM Dan, RM Kelly, CK Lee, and Stuart M. Levitz. 2008.
“The Role of the Mannose Receptor in a Murine Model
of Cryptococcus neoformans infection”, Infect.
Immun., in press, advance online publication April 7,
2008.
- RM Kelly, A Panoskaltsis-Mortari, PA Taylor, GA Holländer,
and Bruce R. Blazar. 2008. “Combining Keratinocyte
Growth Factor with Transient p53 Inhibition Protects Against
Conditioning Regimen-Induced Thymic Epithelial Damage Following
Murine Bone Marrow Transplantation”, manuscript in
preparation for Blood.
- RM Kelly, J Chen, LE Yauch, and Stuart M. Levitz. 2005.
“Opsonic Requirements for Dendritic Cell-Mediated
Responses to Cryptococcus neoformans”, Infect. Immun.
73(1):592-598.
|